J.B. Hunt falls 2.8% after Q3 results show revenue growth but margin pressures

What happened

J.B. Hunt (JBHT) fell 2.8% on October 16, 2026, after third-quarter results beat estimates but showed rising costs that squeezed margins. The company reported demand strength across its transportation services and Intermodal growth that helped lift revenue, but management said driver, fuel, claims and medical costs pushed operating expenses higher. Seeking Alpha and Zacks Investment Research reported the results, and Benzinga said analysts trimmed forecasts after the report. Newsfile Corp reported that the Rosen Law Firm announced an investigation into possible securities claims in October 2026.

How big was the move

The stock closed at $228.78, down 2.8%, after it opened 3.1% below the previous close. Trading volume was 1.5 times its 20-day average, signaling heavier activity than a typical session. The move measured 1.1 times a typical daily move for this stock. The S&P 500 fell 1.1% on the day and the Industrials sector median fell 1.2%, leaving the stock 1.6 percentage points worse than the sector median. The shares' market value was $21.53 billion.

The technical picture

On a short-term basis the stock traded 0.4% below its 20-day moving average and 9.1% below its 50-day moving average, while it was 6.6% below its 200-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend. The Relative Strength Index (14 days) was 42, in a neutral range between 30 and 70. The stock sat 23.7% below its 52-week high, down 3.4% over one month and down 21.3% over three months, yet it rose 64.8% over one year, 50.0 percentage points ahead of the S&P 500. Volatility was 41% annualized over 60 days, higher than 88% of its own readings over five years.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $13.33 billion, which grew 10.6% from a year earlier, and diluted earnings per share were $7.12, which rose 23.4% from a year earlier. Gross margin was 15.0%, up from 14.1% a year earlier, and operating margin was 7.2%, up from 6.9% a year earlier. Management said operating expenses increased to $3.43 billion as rising driver, fuel, claims and medical costs pressured margins. Return on invested capital was 11.1%, and share count over one year decreased by 3.8%.

The stock traded at 32.1 times trailing earnings and 31.3 times expected earnings. That price to trailing earnings level was higher than 81% of its own readings over the past five years; the five-year median was 27.5 times earnings. In other words, investors are paying a premium relative to J.B. Hunt’s recent historical valuations despite the margin headwinds.

Earnings and analyst expectations

J.B. Hunt reported on October 15, 2026, EPS of $1.82 against $1.81 expected, 0.6% above estimates, marking the seventh consecutive quarter the company beat consensus. The company’s average surprise over the last four reports was 4.7% above estimates, and the typical two-day reaction after recent reports has been a fall of 0.9%. Analysts reduced forecasts following the Q3 results, according to Benzinga, even as consensus among 46 analysts remained a Buy with a consensus price target of $289.40, 26.5% above the closing price. Fifty-nine percent of analysts rated the stock Buy. The next report is scheduled for January 21, 2027.

PromtFinance scores rank J.B. Hunt generally in the middle of its sector: Value 55 (Neutral), Growth 59 (Neutral) and Quality 63 (Neutral), with Momentum 73 (Positive) and Stability 68 (Positive). Those scores reflect a mix of solid recent returns and higher valuation metrics, suggesting investors are valuing future growth and profitability despite near-term cost pressures.

What to watch

• October 15, 2026: last report — EPS $1.82 versus $1.81 expected, 0.6% above estimates
• January 21, 2027: next scheduled earnings report
• Consensus price target $289.40, 26.5% above the closing price
• Trading volume on October 16, 2026: 1.5 times its 20-day average
• Rosen Law Firm announced an investigation into possible securities claims (reported October 2026)